Skip to main
APMD

Apnimed Inc (APMD) Earnings Dates & Reports

Apnimed Inc (APMD) Most Recent Earnings

Report Date
Period EndingQ2 2026
Est. EPS-$0.34
Actual EPS$3.92
EarningsBeat

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

Apnimed Inc (APMD) Earnings per Share (EPS) History

Signup for full access
Browse free

Apnimed Inc (APMD) Latest Earnings

The value each APMD share was expected to gain vs. the value each share gained.

Apnimed Inc (APMD) reported its most recent earnings on for Q2 2026, posting earnings per share (EPS) of $3.92. This exceeded analysts' expectations of -$0.34 by 1,252.94%, marking a Beat.

For comparison, Apnimed Inc reported EPS of $0 in the same quarter last year.

The company is expected to announce its next earnings report on , with analysts projecting an EPS of -$0.34.

Apnimed Inc (APMD) Earnings History

Earnings
Est. EPSActual EPSSurprise
Q3 2026
-$0.34
Q2 2026
-$0.34$3.92-1,252.94%

Apnimed Inc (APMD) Earnings Related Price Changes

Earnings announcements may impact a stock’s price. This table highlights the Apnimed Inc’s price movement by comparing the day-before and day-after prices of recent earnings reports, along with the percentage change.

Report datePrice 1D beforePrice 1D afterChange

Apnimed Inc (APMD) Earnings FAQs

Apnimed Inc (APMD) last reported earnings on Sep 8, 2026 for Q2 2026, posting an EPS of $3.92, which Beat the estimate of -$0.34 by 1,252.94%.

For Q2 2026, Apnimed Inc (APMD) reported an EPS of $3.92, exceeding analysts' estimate of -$0.34 by 1,252.94%.

For Q2 2026, Apnimed Inc (APMD) Beat expectations with an actual EPS of $3.92 vs. an estimated EPS of -$0.34.

Following the last earnings report on Sep 8, 2026, Apnimed Inc (APMD)'s stock price moved — from — to —.

The next Apnimed Inc (APMD) earnings call is scheduled for Nov. 3, 2026, where executives will discuss financial results and outlook.

Apnimed Inc (APMD)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.